AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
Mar 13, 2026, 9:30 AM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
PE Ratio | 28.64 | 34.55 | 64.13 | 1.47K | 41.46 | 98.43 |
PEG Ratio | 1.57 | 0.41 | 0.02 | -15.12 | 0.29 | -2.66 |
PS Ratio | 3.73 | 4.49 | 4.75 | 4.39 | 4.98 | 5.39 |
PB Ratio | 4.94 | 5.26 | 5.69 | 4.18 | 8.48 | 10.01 |
P/FCF Ratio | 27.70 | 31.33 | 29.14 | 43.66 | 60.42 | 258.16 |
P/OCF Ratio | 16.99 | 19.89 | 21.50 | 27.55 | 27.61 | 44.26 |
OCF/S Ratio | 21.94 | 22.58 | 22.11 | 15.94 | 18.03 | 12.18 |
Debt / Equity Ratio | 0.74 | 0.73 | 0.79 | 0.78 | 1.30 | 1.39 |
Quick Ratio | 0.74 | 0.64 | 0.68 | 0.76 | 0.76 | 0.68 |
Current Ratio | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 |
Asset Turnover | 0.52 | 0.45 | 0.46 | 0.36 | 0.40 | 0.40 |
Interest Coverage | 7.34 | 5.16 | 2.79 | 0.81 | 3.95 | 2.04 |
Return on Equity | 17% | 15% | 9% | n/a | 20% | 10% |
Return on Assets | 7% | 6% | 3% | n/a | 5% | 2% |
Return on Invested Capital | 10% | 9% | 6% | -1% | 8% | 5% |
Dividend Yield | 2.30% | 2.18% | 2.03% | 2.31% | 2.87% | 2.84% |
Payout Ratio | 65.80% | 75.25% | 130.31% | 3.38K% | 119.14% | 279.40% |
FCF Payout Ratio | 63.63% | 74.83% | 64.74% | 120.40% | 198.73% | 1.49K% |
Gross Profit Margin | 81.12% | 81.95% | 72.06% | 66.76% | 80.09% | 79.82% |
Net Profit Margin | 13.01% | 13% | 7.41% | 0.30% | 12.01% | 5.47% |
Pretax Profit Margin | 16.07% | 15.06% | 5.64% | -0.71% | 14.71% | 6.35% |
Operating Profit Margin | 18.50% | 17.88% | 8.47% | 2.82% | 19.39% | 11.99% |
FCF Margin | 13.45% | 14.34% | 16.32% | 10.06% | 8.24% | 2.09% |
EBITDA Margin | 28.55% | 30.37% | 20.48% | 13.66% | 30.37% | 27.53% |
Add to Watchlist
Select watchlists to add or remove AZNCF